Skip to content

Vir Biotechnology, Inc. VIR Property, plant and equipment at cost

Property, plant and equipment at cost at other companies

Gilead Sciences logo
Gilead SciencesGILD
Nuvation Bio logo
Nuvation BioNUVB
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
Replimune Group logo
Replimune GroupREPL

Other financials

Income statement

See full
Revenue-$29.0K-101%
Gross profit$1.2M-60.2%
Operating income-$132.3M+5.2%
Net income-$125.7M-3.9%
EPS (diluted)-$0.85+3.4%

Balance sheet

See full
Cash & equivalents$283.0M-23.1%
Total debt$95.6M-0.5%
Total equity$812.8M-22.1%
Total assets$1.0B-21.6%

Cash flow

See full
Operating cash flow-$132.4M-69.5%
CapEx$390.0K-76.1%
Free cash flow-$132.8M-66.5%

Valuation

See full
Market cap$1.68B+61.1%
Enterprise value$1.49B+102%
P/S25.6×-24.3×

Profitability

See full
Gross margin96.1%-2.7pp
Operating margin-720.8%-313pp
Net margin-676%-291pp
FCF margin-686.5%-273pp

Returns & leverage

See full
Return on equity-47.7%+3.6pp
Debt / equity0.1×0.0×
Current ratio7.1×+0.3×

Where this comes from

Reported directly by Vir Biotechnology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.

The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vir Biotechnology, Inc.'s property, plant and equipment at cost.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vir Biotechnology, Inc.'s property, plant and equipment at cost?
Vir Biotechnology, Inc. (VIR) reported property, plant and equipment at cost of $103.06M in Q1 2026.
How has Vir Biotechnology, Inc.'s property, plant and equipment at cost changed year-over-year?
Vir Biotechnology, Inc.'s property, plant and equipment at cost increased by 2.5% year-over-year, from $100.55M to $103.06M.
What is the long-term trend for Vir Biotechnology, Inc.'s property, plant and equipment at cost?
Over 3 years (2022 to 2025), Vir Biotechnology, Inc.'s property, plant and equipment at cost has grown at a -6.7% compound annual growth rate (CAGR), from $126.35M to $102.78M.